%0 Journal Article
%T European Ultrahigh-Field Imaging Network for Neurodegenerative Diseases (EUFIND)
%A Alexandre Vignaud
%A Ariane Fillmer
%A Arturo Cardenas-Blanco
%A David Berron
%A Dennis Chan
%A Esben Petersen
%A Fawzi Boumezbeur
%A Geert Jan Biessels
%A Hartwig Siebner
%A Isabella Bj£¿rkman-Burtscher
%A Itamar Ronen
%A Jaco Zwanenburg
%A James B. Rowe
%A Jeroen Hendrikse
%A Julio Acosta-Cabronero
%A Kamil Uludag
%A Ludovic de Rochefort
%A Mark E. Ladd
%A Mark v Buchem
%A Mauro Costagli
%A Michel Bottlaender
%A Michela Tosetti
%A Oliver Kraff
%A Oliver Speck
%A Oskar Hansson
%A Penny Gowland
%A Richard Bowtell
%A Sina Straub
%A Stuart Clare
%A Tony Stoecker
%J Archive of "Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring".
%D 2019
%R 10.1016/j.dadm.2019.04.010
%X The goal of European Ultrahigh-Field Imaging Network in Neurodegenerative Diseases (EUFIND) is to identify opportunities and challenges of 7 Tesla (7T) MRI for clinical and research applications in neurodegeneration. EUFIND comprises 22 European and one US site, including over 50 MRI and dementia experts as well as neuroscientists
%K Magnetic resonance imaging (MRI)
%K Ultrahigh-field MRI
%K Alzheimer's disease (AD)
%K Subjective cognitive decline (SCD)
%K Mild cognitive impairment (MCI)
%K Parkinson's disease (PD)
%K Vascular dementia
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675944/